Article

A metaproteomics-based meta study of samples from patients with inflammatory bowel disease identifies potential markers for diagnosis and therapy monitoring

2025-11-07

Abstract excerpt

Inflammatory bowel disease (IBD) is a chronic intestinal disorder involving recurring inflammation and pronounced microbial dysbiosis. Comprehensive studies with large patient cohorts are required to Identify meaningful biomarker candidates for diagnosing and monitoring IBD. In this large-scale meta-study of over 600 samples based on fecal metaproteomics, our goal was to validate known biomarkers and discover new...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: a7014857-83ec-59b1-8d12-a7ef20f932f0
DOI: 10.1101/2025.11.06.684320

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A metaproteomics-based meta study of samples from patients with inflammatory bowel disease identifies potential markers for diagnosis and therapy monitoringDOI 10.1101/2025.11.06.684320Read

Multi-omics phenotyping characterizes molecular divergence underlying different clinical scenarios of inflammatory bowel diseaseSemantic proximity Read

Ultra-sensitivity metaproteomics redefines the gut “dark metaproteome”, uncovering host-microbiome interactions and drug targets in intestinal inflammatory diseasesSemantic proximity Read

Proteomics and metabolomics in inflammatory bowel disease.Semantic proximity Read

Metaproteomics as a tool for studying the protein landscape of human-gut bacterial speciesSemantic proximity Read

MetaPro-IQ: a universal metaproteomic approach to studying human and mouse gut microbiotaSemantic proximity Read

Metaproteomics of colonic microbiota unveils discrete protein functions among colitic mice and control groupsSemantic proximity Read

The human gut metaproteomics: insights on wet and dry workflowsSemantic proximity Read

Multi-omics data integration identifies novel biomarkers and patient subgroups in inflammatory bowel diseaseSemantic proximity Read

Application of Proteomics to Inflammatory Bowel Disease Research: Current Status and Future PerspectivesSemantic proximity Read

Metaproteomics reveals potential signatures of disease-specific alterations in the gut microbial proteolytic events in inflammatory bowel diseaseSemantic proximity Read

A microbiome meta-transcriptomics pipeline identifies a novel human neutrophil elastase inhibitor that protects the colonic epithelial barrierSemantic proximity Read

Identifying Robust Biomarkers for the Diagnosis and Subtype Distinction of Inflammatory Bowel Disease through Comprehensive Serum Metabolomic ProfilingSemantic proximity Read